Do you write news releases? And want help?
We offer free pre-publication review of releases. SEE MORE →
Early on the CNN story makes a bold claim that the test could save thousands of lives, yet in many cases, early detection of cancer does not guarantee a longer, healthier life.
The news release doesn’t provide any data. Nor does it mention how memory, performance, motivation, or mood were measured.
The story may mislead people into thinking that if they pop a pressure pill each day, they will avoid Alzheimer’s Disease. That’s unproven.
The release asserts that stem cells are a promising approach to regenerating a torn meniscus, but the data are very limited.
News stories must be careful to explain study limitations so that people come away understanding what a study couldn’t measure.
While robotic surgery may be “not inferior” to standard therapy for bladder cancer, it does have added costs and a longer procedure time.
The evidence cited here is still very preliminary, a finding we also noticed in another recently reviewed article on using genetic testing for targeting depression meds.
Changes in surrogate markers don’t necessarily translate to better health outcomes affecting patient pain and quality of life.
It’s way too soon to know if melanoma blood test will save ‘thousands of lives’ -- despite claim in CNN story https://t.co/CG114UF3QN h/t @AdeAdamson @djsampson
University teases sweet solution to older adults’ memory problems https://t.co/OJLSsslOK2
Tips & Resources for Analyzing Health Care Claims
Podcast: The language of cancer
Podcast: The new & (un)improved doctor-patient relationship
Podcast: Gut Punch – Marketing Microbiome Hype